CTNM
UNKNOWNContineum Therapeutics, Inc.
CIK: 0001855175
Last activity: 3 days ago
Financial Metrics
As of Sep 30, 2025 (10-Q)
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Lorrain Daniel S. Chief Scientific Officer | 0 | 6 | -$163K | 156,052 shares $2.50M |
| Watkins Tim CMO & Head of Development | 0 | 3 | -$95K | 811 shares $11K |
| Stengone Carmine N. CEO and President | 0 | 1 | -$6K | 14,954 shares $239K |
Recent Transactions
400 shares @ $16.00
$6K
Feb 11, 2026
400 shares @ $16.00
$6K
Feb 11, 2026
3,000 shares @ $14.82
$44K
Feb 3, 2026
1,170 shares @ $15.25
$18K
Feb 3, 2026
2,800 shares @ $14.09
$39K
Jan 28, 2026
811 shares @ $14.48
$12K
Jan 28, 2026
3,670 shares @ $10.35
$38K
Jan 5, 2026
500 shares @ $11.13
$6K
Jan 5, 2026
3,611 shares @ $12.06
$44K
Dec 29, 2025
4,170 shares @ $12.23
$51K
Dec 23, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.